Loss of IRF7 accelerates acute myeloid leukemia progression and induces VCAM1-VLA-4 mediated intracerebral invasion.

Loss of IRF7 accelerates acute myeloid leukemia progression and induces VCAM1-VLA-4 mediated intracerebral invasion.
复制标题

DOI:
10.1038/s41388-022-02233-w
复制
发表时间:
2022-04
期刊:
影响因子:
8
通讯作者:
Zheng, Guoguang
Zheng, Guoguang
中科院分区:
医学1区
文献类型:
--
作者:
Wang, Hao;Zhang, Dongyue;Cui, Xiaoxi;Dai, Yibo;Wang, Chenchen;Feng, Wenli;Lv, Xiaoqian;Li, Yifei;Wang, Lina;Ru, Yongxin;Zhang, Yingchi;Ren, Qian;Zheng, Guoguang

文献摘要

参考文献

被引文献

相似文献

Interferon regulatory factor 7 (IRF7) is widely studied in inflammatory models. Its effects on malignant progression have been documented mainly from the perspective of the microenvironment. However, its role in leukemia has not been established. Here we used MLL-AF9-induced acute myeloid leukemia (AML) mouse models with IRF7 knockout or overexpression and xenograft mouse models to explore the intrinsic effects of IRF7 in AML. AML-IRF7−/− mice exhibited accelerated disease progression with intracerebral invasion of AML cells. AML-IRF7−/− cells showed increased proliferation and elevated leukemia stem cell (LSC) levels. Overexpression of IRF7 in AML cells decreased cell proliferation and LSC levels. Furthermore, overexpression of transforming growth-interacting factor 1 (TGIF1) rescued the enhanced proliferation and high LSC levels caused by IRF7 deficiency. Moreover, upregulation of vascular cell adhesion molecule 1 (VCAM1), which correlated with high LSC levels, was detected in AML-IRF7−/− cells. In addition, blocking VCAM1-very late antigen 4 (VLA-4) axis delayed disease progression and attenuated intracerebral invasion of AML cells. Therefore, our findings uncover the intrinsic effects of IRF7 in AML and provide a potential strategy to control central nervous system myeloid leukemia.
P2X7 通过上调 Pbx3 促进 MLL-AF9 诱导的急性髓系白血病的进展。
DOI: 10.3324/haematol.2019.243360
发表时间: 2021-05-01
期刊: Haematologica
影响因子: 10.1
作者:
Feng W;Yang X;Wang L;Wang R;Yang F;Wang H;Liu X;Ren Q;Zhang Y;Zhu X;Zheng G
通讯作者: Zheng G
老年人群中原发性中枢神经系统淋巴瘤的诊断,预后和治疗(综述)。
DOI: 10.3892/ijo.2021.5180
发表时间: 2021-03
影响因子: 5.2
作者:
Liu Y;Yao Q;Zhang F
通讯作者: Zhang F
SUV39H1 调节 MLL-AF9 诱导的急性髓系白血病的进展
DOI: 10.1038/s41388-020-01495-6
发表时间: 2020-12
期刊: Oncogene
影响因子: 8
作者:
Chu Y;Chen Y;Guo H;Li M;Wang B;Shi D;Cheng X;Guan J;Wang X;Xue C;Cheng T;Shi J;Yuan W
通讯作者: Yuan W
DOI: 10.1093/nar/gky680
发表时间: 2018-09-28
影响因子: 14.9
作者:
Guca E;Suñol D;Ruiz L;Konkol A;Cordero J;Torner C;Aragon E;Martin-Malpartida P;Riera A;Macias MJ
通讯作者: Macias MJ
DOI: 10.15252/embj.2018101067
发表时间: 2019-07-01
期刊: EMBO JOURNAL
影响因子: 11.4
作者:
Parajuli, Parash;Singh, Purba;Atfi, Azeddine
通讯作者: Atfi, Azeddine